Type 2 Diabetes News and Research

Latest Type 2 Diabetes News and Research

Keto vs. low-fat diets: which is more sustainable in the long term?

Researchers investigated whether commercial weight loss diets meet nutrient requirements.

24 May 2023

Is COVID-19 diagnosis associated with the risk and incidence of type 1 diabetes?

Researchers assessed the incidence and risk of type 1 diabetes in children with coronavirus disease 2019.

24 May 2023

What is the efficacy, safety, and tolerability of novel danuglipron in adults with type two diabetes?

Researchers assessed the safety and efficacy of danuglipron in type 2 diabetes (T2D) patients.

24 May 2023

Rural patients have worse diabetic quality metrics than urban counterparts

Mayo Clinic researchers conducted a study within their health care system to identify factors associated with quality of care among rural and urban patients with diabetes.

24 May 2023

Oral antivirals Molnupiravir and Nirmatrelvir-Ritonavir lower COVID-19 risks in type 2 diabetes patients

Research investigates the effectiveness of oral antiviral medications, Molnupiravir and Nirmatrelvir-Ritonavir, in treating patients with type 2 diabetes and mild to moderate COVID-19. The study aims to determine the efficacy of these medications in reducing adverse outcomes in this specific population.

24 May 2023

FDA clearance of BU-developed bionic pancreas brings new hope for Americans with type 1 diabetes

A bionic pancreas - a wearable, pocket-sized, automated insulin delivery device - that was first developed in a Boston University lab has been cleared by the US Food and Drug Administration (FDA). The iLet Bionic Pancreas is now commercially available, bringing fresh hope to the almost two million Americans with type 1 diabetes.

23 May 2023

Advances in automated insulin delivery systems reduce disease management burden for patients with diabetes

Type 1 diabetes affects 46.3 million people worldwide, and the number of people affected increases by about 3% each year.

23 May 2023

Metabolic sensors may play a role in the development of Alzheimer's disease, study suggests

It's well-known that people with Type 2 diabetes are at an increased risk of developing Alzheimer's disease, but the reason why isn't fully understood and is an area of current research.

22 May 2023

Cardiovascular risk score decreases after one year of semaglutide use in obese patients, study shows

New research presented at this year's European Congress on Obesity in Dublin, Ireland shows that patients treated with the obesity drug semaglutide have a decreased cardiovascular risk score after one year of use.

22 May 2023

People with higher long-term hair glucocorticoid levels more likely to develop heart, circulatory diseases

New research being presented at this year's European Congress on Obesity (ECO) in Dublin, Ireland (17-20 May) suggests that glucocorticoid levels (a class of steroid hormones secreted as a response to stress) present in the hair of individuals may indicate which of them are more likely to suffer from cardiovascular diseases (CVD) in the future.

22 May 2023

Multicenter, 1-year-long real-world study shows effectiveness of semaglutide for weight loss

New research presented at this year's European Congress on Obesity (ECO2023, Dublin, 17-20 May) shows that the obesity drug semaglutide is effective for weight loss in a multicentre, 1-year-long real-world study.

22 May 2023

Toddler’s gut bacteria highly predictive of body mass index at age 5

The make-up and volume of gut bacteria in toddlers at 3.5 years old is predictive of body mass index (BMI) at age 5, irrespective of whether they are born prematurely or not, according to new research, being presented at this year's European Congress on Obesity (ECO) in Dublin, Ireland (17-20 May).

22 May 2023

Tirzepatide improves body composition across a range of adult age groups, study shows

A new analysis of SURMOUNT-1, the first Phase 3 study of tirzepatide in adults for chronic weight management shows that tirzepatide improves body composition across a range of adult age groups.

19 May 2023

Is there an association between long-term plasma caffeine intake and adiposity, type 2 diabetes, and cardiovascular diseases?

Investigate the effects of long-term exposure to higher plasma caffeine concentrations on T2D, adiposity, and cardiovascular diseases.

18 May 2023

Weekend catch-up sleep may minimize the risk of hyperuricemia in postmenopausal women

Sleep deprivation, especially common during postmenopause, has been linked with a number of health problems, including hyperuricemia (elevated serum uric acid), which can often lead to gout and other life-threatening conditions such as heart disease.

17 May 2023

How does tobacco usage impact quality of life?

Researchers evaluated the impact of tobacco usage on the health-associated quality of life.

17 May 2023

A novel approach to quantify personal information contained within gut metagenome data

Researchers used shotgun sequencing to extract human reads from DNA in fecal samples

17 May 2023

Myosteatosis linked to increased risk of major adverse events and death

Asymptomatic adults with a high accumulation of fat in their muscles, known as myosteatosis, are at an increased risk of major adverse events and death, according to a study published in Radiology, a journal of the Radiological Society of North America.

16 May 2023

Women experiencing severe hot flashes after menopause more likely to develop metabolic syndrome

Women who experience more severe hot flashes after menopause are more likely to develop metabolic syndrome and high blood pressure, according to research presented at the 25th European Congress of Endocrinology in Istanbul.

16 May 2023

Obesity undermines COVID-19 vaccines

Researchers examine the impact of obesity on COVID-19 outcomes and the effectiveness of vaccines in individuals with obesity. Using data from Scotland, the study explores the relationship between body mass index (BMI) and hospitalization/mortality due to COVID-19.

15 May 2023

Type 2 Diabetes News and Research

Latest Type 2 Diabetes News and Research

Keto vs. low-fat diets: which is more sustainable in the long term?

Is COVID-19 diagnosis associated with the risk and incidence of type 1 diabetes?

What is the efficacy, safety, and tolerability of novel danuglipron in adults with type two diabetes?

Rural patients have worse diabetic quality metrics than urban counterparts

Oral antivirals Molnupiravir and Nirmatrelvir-Ritonavir lower COVID-19 risks in type 2 diabetes patients

FDA clearance of BU-developed bionic pancreas brings new hope for Americans with type 1 diabetes

Advances in automated insulin delivery systems reduce disease management burden for patients with diabetes

Metabolic sensors may play a role in the development of Alzheimer's disease, study suggests

Cardiovascular risk score decreases after one year of semaglutide use in obese patients, study shows

People with higher long-term hair glucocorticoid levels more likely to develop heart, circulatory diseases

Multicenter, 1-year-long real-world study shows effectiveness of semaglutide for weight loss

Toddler’s gut bacteria highly predictive of body mass index at age 5

Tirzepatide improves body composition across a range of adult age groups, study shows

Is there an association between long-term plasma caffeine intake and adiposity, type 2 diabetes, and cardiovascular diseases?

Weekend catch-up sleep may minimize the risk of hyperuricemia in postmenopausal women

How does tobacco usage impact quality of life?

A novel approach to quantify personal information contained within gut metagenome data

Myosteatosis linked to increased risk of major adverse events and death

Women experiencing severe hot flashes after menopause more likely to develop metabolic syndrome

Obesity undermines COVID-19 vaccines

Industry Focus eBook - Medical device (1st edition) eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Type 2 Diabetes News and Research

Latest Type 2 Diabetes News and Research

Industry Focus eBook - Medical device (1st edition) eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Newsletters you may be interested in